Ref.: BL-RE-090725Manufacturer ref.: EH147RBX10 10 x 96 tests
€4,995.00 excl. VAT
Human CytokeRatin 8/KRT8 quantitates human Cytokeratin 8/KRT8 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Cytokeratin 8/KRT8.
Accession number
AA960620 ; AL022697 ; AU019895 ; C CY K2C8 ; CARD2 ; CB186 ; CK 8 ; CK8 ; CK-8 ; cyk8 ; CYKER ; cytokératine 8 ; cytokératine 8 (370 AA) ; Cytokératine endo A ; cytokératine-8 ; Cytokératine-A ; Drek8 ; EndoA ; ETID33550.23 ; ETID43142.23 ; ETID43142.8 ; kératine dure ; K2C8 ; K8 ; K-8 ; KERA ; kératine 8 ; Kératine 8, type II ; complexe de kératine 2, basique, gène 8 ; Kératine, type 2, gène 8 ; kératine, cytosquelette de type II 8 ; kératine-8 ; KO ; Krt-2.8 ; krt2-8 ; KRT8 ; PROTÉINE DE QUALITÉ FAIBLE : kératine, cytosquelette de type II 8 ; sb :cb186 ; cytokératine de type II A (no0,8) ; kératine de type II Kb8 ; wu :fa20h05 ; wu :fa95h10 ; wu :fb96c06 ; Zfk8 ; zf-K8
Dose range
0.410 to 100 pg/ml
Sensitivity of the dosage
0.41 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Human CytokeRatin 8/KRT8 quantitates human Cytokeratin 8/KRT8 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Cytokeratin 8/KRT8.
Human CytokeRatin 8/KRT8 quantitates human Cytokeratin 8/KRT8 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Cytokeratin 8/KRT8.
Cytokeratin 8 belongs to the type II keratin family on the long arm of chromosome 12. Type I and II keratins ss-heteropolymerize to form intermediate-sized filaments in epithelial cell cytoplasm. Cytokeratin 8 usually dimerizes with keratin 18 to form an intermediate filament in single-layer epithelial cells. This protein plays a role in maintaining cellular structural integrity and also works in signal transduction and cell differentiation. The mutations of this gene cause cryptogenic cirrhosis.
Sensitivity
Sensitivity of the dosage: 0.41 pg/ml.
Measurement range
Dose range: 0.410 to 100 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.